Register for 2023 Pharmacy Practice Seminar |
|
Returning Later |
|
Immunization Update |
Session A:
Session B:
Session C:
Creating an Optimal Work Environment |
Adapting to Regulatory Changes in Telemedicine Prescribing |
Prescribing & Monitoring Controlled Substances: Plunging into the PMP: A Deeper Dive into Substance Use and Pharmacy Practice
This session counts towards the TSBP prescribing and monitoring controlled substances credit requirement for new Texas licensed pharmacists
|
Disclosure: Dr. Garling does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
Breaking Issues in Opioid Use Disorder Treatment and Harm Reduction |
OTC Topic: Allergic Rhinitis |
Law: Texas Pharmacy Law Update + Q&A
This session counts as one hour of CE for TSPB Law Requirement
|
Julie Spier of Katy was appointed to the board in 2018 and has served as President of the Board since 2019. She is also the Director of Pharmacy Operations for the Southern division of Albertsons, Randalls, and Tom Thumb, overseeing 142 locations in Texas, Louisiana and Arkansas. Through the years with Randalls, she has served in the capacity of a pharmacist, pharmacy manager, regional pharmacy manager, and patient care services pharmacy manager in addition to her current title. Ms. Spier received a Bachelor of Science in Biology from Sam Houston State University and a Bachelor of Science degree in Pharmacy from the University of Houston College of Pharmacy.
Disclosure: Julie Spier does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
New Drug Update - Community Focus
|
Disclosure: Dr. Ryan does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
Mental Health Awareness: ADHD Treatment Update |
• Describe the risks of comorbid psychiatric and medical comorbidities in people with Attention-deficit/hyperactivity disorder (ADHD)
• Explain the risks and prevention of medication diversion and misuse in people with ADHD
• Design an individualized management plan for people with ADHD
About the Speaker
Stephen R. Saklad, Pharm.D., BCPP
Director, Psychiatric Pharmacy Program
Pharmacotherapy Education and Research Center
UT Health Science Center San Antonio
Dr. Saklad is a Clinical Professor at The University of Texas College of Pharmacy and a Pharmacist at San Antonio State Hospital since 1979. He has focused his career on clinical care, teaching, and research to improve the quality of life and function in the serious and persistently mentally ill. He helped to create a clinical research unit at San Antonio State Hospital and developed the first websites for The University of Texas College of Pharmacy and the College of Psychiatric and Neurologic Pharmacists (CPNP). He is the Director of the University of Texas Psychiatric Pharmacy Program in San Antonio, having trained over 70 advanced practice pharmacists in psychiatric pharmacy. Dr. Saklad is a Founding Member of CPNP, served on the CPNP Board of Directors and was the founding senior editor of their peer-reviewed journal, the Mental Health Clinician. He has published articles and presented to many groups around the country on a variety of pharmacy and mental health-related topics. He is a principal or co-investigator for several studies of the efficacy and adverse effects of Phase II, III, and IV psychotropic agents in schizophrenia, mood disorders, and other serious mental illnesses, as well as their pharmacokinetics and interactions. He has received several honors, most recently the Judith J. Saklad Memorial Award from CPNP in 2012 and the Teaching Excellence Award from the UT College of Pharmacy in 2013.
Disclosure: Dr. Stephen Saklad has the following relevant financial relationships, potential or perceived, with commercial or conflicts of interest to disclose:
Speakers Bureau: Actavis, Otsuka, Sunovion
Consultant: Janssen, Jazz, Otuska, Teva
Other: Member of Pharmacists Foundation, Business Development Council for San Antonio
Mental Health Awareness: Treatment of Agitation in Neurocognitive Disorders
This session counts towards the TSBP mental health awareness credit requirement
|
Disclosure: Dr. Schillerstrom has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.
Panel: Technology in Community Pharmacy
|
Shifting Scales: Navigating Weight Loss and Wellness
|
Diabetes Care Update and the Pharmacist’s Role
|
Human Trafficking Awareness: Identifying and Responding to Victims of Human Trafficking for Pharmacists & Pharmacy Technicians
This session counts for the one hour TSBP requirement of human trafficking prevention
|
Dr. Ashley Garling graduated Rho Chi with honors from the MCV/Virginia Commonwealth University School of Pharmacy. Her career path went from community pharmacy management, inpatient pharmacy with an oncology focus, to corporate clinical coordinator, and media spokeswoman. She is now a clinical assistant professor at The University of Texas at Austin College of Pharmacy where she serves as a communication, media, and patient engagement specialist. Dr. Garling is the principal investigator (PI) and Co-PI for research projects in community pharmacy settings spanning from telehealth, HIV PrEP, mental health, patient counseling, and medication adherence. She currently serves as president of the Capital Area Pharmacist Association, Affairs Public Policy Council Member, and Public Policy Council Member of the Texas Pharmacist Association. Her career pillars are focused on public activation, empowerment of underheard voices, and health education. In 2020-21, Dr. Garling was awarded the Dr. Carolyn Brown DEAI Champion Award and the 2021 Teaching Excellency Award in recognition of her outstanding contributions to diversity, inclusion, and pharmacy education.
Disclosure: Dr. Garling does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
Sterile Compounding: 797 Updates: 7 Key Takeaways
This session counts towards the TSBP requirement for sterile compounding maintenance
|
Sterile Compounding: USP <797> Update: A Deeper Dive
This session counts towards the TSBP requirement for sterile compounding maintenance
|
Preceptor: Recognizing Mental Health Challenges and Burnout with Students
This session counts towards preceptor CPE credit requirements
|
Disclosure: Dr. Catanzano does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
Preceptor: Precepting Generation Z: Understanding Cultural and Generational Differences in the Workplace
This session counts towards preceptor CPE credit requirements
|
Disclosure: Dr. Kubes does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
Pain Management: Pain Management in the Hospital
This session counts the TSBP pain management requirement - note this requirement ends on Sept 1
The session will be availalbe by August 1 for those who still need to meet the requirement.
|
Looking at Pharmacy Practice through the Transitions-of-Care Lens
|
Topic TBA
|
Exhibitor - Moderna
|
Exhibitor - Pharmacists Mutual Insurance Company
|
|
|||||||||||||||||||||||||||||||||
Sponsor - H-E-B Pharmacy
|
Texas Pharmacy Alumni Relations
|
71st Pharmacy Practice Seminar - OVERALL EVALUATION
|